Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Abilify May Be Linked to Gambling Problems, Impulse Control Side Effects: Study November 3, 2014 Irvin Jackson Add Your Comments New research suggests that there may be a link between side effects of Abilify and severe impulse control problems, such as compulsive gambling, sex addiction and other issues that may have a severe impact an individual’s life. In a study published by the medical journal JAMA Internal Medicine late last month, researchers from the Institute for Safe Medication Practices (ISMP), Harvard Medical School and the University of Ottawa evaluated a class of drugs known as dopamine receptor agonists, which are most commonly prescribed for treatment of Parkinson’s disease, restless leg syndrome and hyperprolactinemia. Although Abilify is a partial dopamine receptor agonists, researchers found that the same signals for gambling and other impulse control problems with Abilify were seen among users of the antipsychotic medication, which is a widely used blockbuster drug generating over $6.4 billion in annual sales. Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Abilify Lawsuits Side Effects of Abilify May Increase the Risk of Compulsive Gambling, Shopping and Other Addictive Behaviors Learn More SEE IF YOU QUALIFY FOR COMPENSATION Researchers conducted a retrospective analysis of 2.7 million adverse event reports submitted to federal health regulators between 2003 and 2012, using data from the FDA Adverse Event Reporting System. The study specifically looked for cases that described abnormal behavior. “We identified 1,580 events indicating impulse control disorders from the United States and 21 other countries: 710 for dopamine receptor agonist drugs and 870 from other drugs,” the researchers reported. “The dopamine receptor agonist drugs had a strong signal associated with these impulse control disorders.” There are six FDA-approved dopamine agonists currently on the market. The Parkinson’s disease drugs Mirapex and Requip were most strongly linked to incidents of impulse control problems among the dopamine receptor agonists, leading to gambling addictions and hypersexuality, and even compulsive shopping. However, a safety signal was also seen for Abilify gambling and impulse control problems, with at least 37 reports found specifically involving this one medication. Researchers noted in their findings that drug manufacturers have failed to provide adequate warnings about the risk of impulsive behavior on the drugs, indicating that information about the risk dates back to at least 2009, when a study found that approximately 18% of patients taking a dopamine agonist for treatment of Parkinsons disease could suffer from compulsive behavior side effects. “Our findings confirm and extend the evidence that dopamine receptor agonist drugs are associated with these specific impulse control disorders,” researchers involved in the latest study concluded. “At present, none of the dopamine receptor agonist drugs approved by the FDA have boxed warnings as part of their prescribing information. Our data, and data from prior studies, show the need for more prominent warnings.” Abilify Side Effects and Concerns Abilify (ariprazole) is the most widely used medication of those evaluated by the researchers, which was approved by the FDA in 2002 for treatment of schizophrenia, bipolar disorder and other major depressive disorders. The medication has also been widely used to treat irritability, aggression, mood swings and other behavior issues. Amid aggressive marketing that has promoted Abilify as safe and effective, the medication has grown to become the top-selling brand name drug in the United States, generating sales of nearly $6.5 billion in 2013. A large portion of the prescriptions involve questionable use among children for conditions such as attention-deficit hyperactivity disorder (ADHD) or other disruptive behaviors. In August 2013, the Office of the Inspector General at the Department of Health and Human Services (DHHS) launched an investigation into the prescription of Abilify, Risperdal and similar antipsychotics to children. The investigation came as concerns increased over the rampant prescription of powerful psychotropic drugs to those under the age of 18, often for psychological disorders the drugs were not designed to treat. In recent years, there has been increasing concerns about the use of Abilify and other atypical antipsychotic medications among children and teens, potentially exposing them to a number of serious side effects, including a risk of weight gain, childhood diabetes and other health problems. While all atypical antipsychotic medications have been associated with an increased risk of weight gain and diabetes, research has indicated that the risk of childhood diabetes from Abilify may be 7.72 percent above normal when average doses of the medication are used. This latest study did not detail what impact on impulse control side effects of Abilify may have on children and teens, who already have less impulse control naturally than adults. Tags: Abilify, Antipsychotics, Bristol Myers Squibb, Childrens Drug, Diabetes, Mirapex, Otsuka Pharmaceutical Co, Parkinsons Disease, Requip Image Credit: | More Abilify Lawsuit Stories Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019 Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019 Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018 2 Comments c. December 4, 2015 3 weeks on this and suddenly I’m a compulsive online shopper. I don’t think I did enough damage to sue over, but I definitely screwed my life up for at least the next few months. After spending the last 5 years of my life getting my finances in order this has been upsetting to say the least. Coming of this medication as we speak. D. Brown December 10, 2014 my daughter was prescribed This medicine for PTSD, my daughter had severe side affects and SHOULD have never been given this, she was just 14 years of age. Pending lawsuit against Otsuka and treating Physician. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025) MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
Public Citizen Files Lawsuit To Get FDA to Add Impulse Control Warning Added To Requip, Similar Parkinson’s Disease Drugs May 6, 2019
Settlement for Abilify Gambling Cases To Be Reviewed With Parties and Judge This Week February 19, 2019
Trials for Six “Fast-Tracked” Abilify Gambling Cases Expected To Begin in Summer 2019 December 12, 2018
6 Bard PowerPort Lawsuits Selected for Bellwether Trials in Federal MDL (Posted: today) A federal judge has identified the six Bard PowerPort lawsuits that will serve as the first bellwether trials, to test allegations that the port catheters were defectively designed. MORE ABOUT: BARD POWERPORT LAWSUITCourt Indicates Bard PowerPort MDL Bellwether Lawsuits Should Include 3 Infection, 2 Thrombosis and 1 Fracture Case (05/06/2025)Lawyers Proposed 11 Bard Implantable Port Catheter Lawsuits as Bellwether Trial Candidates (04/30/2025)Bard PowerPICC Intravascular Catheter Leaks Linked to Reports of Serious Injuries: FDA (04/21/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: 3 days ago) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: 4 days ago) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)